Long-Term Hepatitis B Surface Antigen Profile and Seroclearance Following Antiviral Treatment: A Single-Center, Real-World Cohort Study

Hepatitis B surface antigen (HBsAg) seroclearance, an indicator of recovery from hepatitis B virus (HBV) infection, is uncommon in long-term nucleos(t)ide analog (NUC) therapy. We compared the incidence of HBsAg seroclearance in patients with and without NUC discontinuation to identify predictors of...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Chih-Wen, Yang, Chen-Ta, Su, Pei-Yuan, Chen, Yang-Yuan, Huang, Siou-Ping, Yen, Hsu-Heng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10669103/
https://www.ncbi.nlm.nih.gov/pubmed/38001966
http://dx.doi.org/10.3390/biomedicines11112966

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10669103/
https://www.ncbi.nlm.nih.gov/pubmed/38001966
http://dx.doi.org/10.3390/biomedicines11112966

Ejemplares similares